1-6 of 6
cytokine release syndrome
Close
Sort by
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.
https://doi.org/10.1182/hematology.2019000370
Published: 2019
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Tania Jain, Mark R. Litzow
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 25–34.
https://doi.org/10.1182/asheducation-2018.1.25
Published: 2018
Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.
https://doi.org/10.1182/asheducation-2016.1.567
Published: 2016
Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.
https://doi.org/10.1182/asheducation-2014.1.559
Published: 2014
Journal Articles

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Eva Hellström-Lindberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 161–166.
https://doi.org/10.1182/asheducation-2005.1.161
Published: 2005
Journal Articles

Diffuse Aggressive Lymphoma

Richard I. Fisher, Thomas P. Miller, Owen A. O'Connor
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 221–236.
https://doi.org/10.1182/asheducation-2004.1.221
Published: 2004